Press Releases

The following are our corporate Press Releases to help provide you with recent information about BDC Laboratories.

  • June 14, 2011
    BDC Laboratories Releases Stent, Stent Graft, and Transcatheter Heart Valve Simulated Use Test Systems

    Endovascular stents, stent grafts, and transcatheter heart valve, (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices. BDC Laboratories has released new technology to aid the medical device industry with their product design testing by providing physiologic simulated use test systems.

  • May 20, 2011
    BDC Laboratories Releases Transcatheter Heart Valve Device Testing Technologies

    Positive clinical outcomes for transcatheter aortic valve implantation (TAVI) from clinical trials presented at the American Association for Thoracic Surgery and the EuroPCR 2011 annual meetings were significant for the high-risk patient, ineligible for surgery with aortic valve stenosis. Further research and product development is currently ongoing worldwide to address complications associated with TAVI. To assist with this research effort, BDC Laboratories has released several technologies aiding medical device companies with their product testing for transcatheter heart valve devices.